Synchronized cycles of bacterial lysis for in vivo delivery
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body. It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbor disease and thus provide a natural platform for the development of engineered therapies. Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ. Here we engineer a clinically relevant bacterium to lyse synchronously ata threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. Asa proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies, we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone.Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An interesting general approach implements engineered bacterial lysis, which enables antitumor protein production or release only when a predefined population density of bacteria is reached (154–157).”
From The microbiome and human cancer (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
A synchronized quorum of genetic clocks
Danino, T., Mondragón-Palomino, O., Tsimring, L., & Hasty, J. (2010) · Nature · doi:10.1038/nature08753 · Cited by 992
Self-citationLeone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, A. F., Nadimpalli, A., Hubert, N., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.006 · Cited by 911
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 1×
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citation
Cited by
Items 101–200 of 782
Inducible cell-to-cell signaling for tunable dynamics in microbial communities
Miano, A., Liao, M. J., & Hasty, J. (2020) · Nature Communications · doi:10.1038/s41467-020-15056-8 · Cited by 94
Self-citationZhao, R., Li, Z., Sun, Y., Ge, W., Wang, M., Liu, H., Xun, L., & Xia, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2070391 · Cited by 102
Engineered bacteria detect tumor DNA
Cooper, R. M., Wright, J. A., Ng, J. Q., Goyne, J. M., Suzuki, N., Lee, Y.-K., Ichinose, M., Radford, G., Ryan, F. J., Kumar, S., et al. (2023) · Science · doi:10.1126/science.adf3974 · Cited by 102
Self-citationEngineering advanced cancer therapies with synthetic biology
Wu, M.-R., Jusiak, B., & Lu, T. K. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0121-0 · Cited by 114
Light-powered Escherichia coli cell division for chemical production
Ding, Q., Ma, D., Liu, G., Li, Y., Guo, L., Gao, C., Hu, G., Ye, C., Liu, J., Liu, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16154-3 · Cited by 90
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
Pouncey, A. L., Scott, A. J., Alexander, J. L., Marchesi, J. R., & Kinross, J. K. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.868 · Cited by 114
Engineered Bacteria Enhance Immunotherapy and Targeted Therapy through Stromal Remodeling of Tumors
Thomas, S. C., Madaan, T., Kamble, N. S., Siddiqui, N. A., Pauletti, G. M., & Kotagiri, N. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101487 · Cited by 106
Yang, Y., Chu, B., Cheng, J., Tang, J., Song, B., Wang, H., & He, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-28920-6 · Cited by 94
RetractedEffects of microbiota on anticancer drugs: Current knowledge and potential applications
Huang, J., Liu, W., Kang, W., He, Y., Yang, R., Mou, X., & Zhao, W. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104197 · Cited by 103
Yu, M., Hu, S., Tang, B., Yang, H., & Sun, D. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108202 · Cited by 96
Future systems and control research in synthetic biology
Vecchio, D. D., Qian, Y., Murray, R. M., & Sontag, E. D. (2018) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2018.04.007 · Cited by 102
Using Synthetic Biology to Engineer Spatial Patterns
Santos‐Moreno, J., & Schaerli, Y. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800280 · Cited by 81
Sequence-Based Characterization of Intratumoral Bacteria—A Guide to Best Practice
Walker, S. P., Tangney, M., & Claesson, M. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00179 · Cited by 91
Active structuring of colloids through field-driven self-assembly
Liljeström, V., Chen, C., Dommersnes, P., Fossum, J. O., & Gröschel, A. H. (2018) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2018.10.008 · Cited by 92
Recent developments of microfluidics as a tool for biotechnology and microbiology
Scheler, O., Postek, W., & Garstecki, P. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.08.004 · Cited by 94
Honjo, H., Iwasaki, K., Soma, Y., Tsuruno, K., Hamada, H., & Hanai, T. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.08.007 · Cited by 81
Engineering Bacteria and Bionic Bacterial Derivatives with Nanoparticles for Cancer Therapy
Yin, T., Diao, Z., Blum, N. T., Qiu, L., Ma, A.-Q., & Huang, P. (2021) · Small · doi:10.1002/smll.202104643 · Cited by 85
Bacterially mediated drug delivery and therapeutics: Strategies and advancements
Wu, L., Bao, F., Li, L., Yin, X., & Hua, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114363 · Cited by 83
Microfluidics and single-cell microscopy to study stochastic processes in bacteria
Potvin-Trottier, L., Luro, S., & Paulsson, J. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.12.004 · Cited by 93
Chang, H., Zúñiga, A., Conejero, I., Voyvodic, P. L., Gracy, J., Fajardo-Ruiz, E., Cohen‐Gonsaud, M., Cambray, G., Pageaux, G., Meszaros, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25538-y · Cited by 87
Genetically engineered bacterium: Principles, practices, and prospects
Liu, Y., Feng, J., Pan, H., Zhang, X., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.997587 · Cited by 92
Salmonella -Mediated Cancer Therapy: An Innovative Therapeutic Strategy
Mi, Z., Feng, Z., Li, C., Yang, X. H., Ma, M., & Rong, P. (2019) · Journal of Cancer · doi:10.7150/jca.32650 · Cited by 83
Versatile biomanufacturing through stimulus-responsive cell–material feedback
Dai, Z., Lee, A. J., Roberts, S., Sysoeva, T. A., Huang, S., Dzuricky, M. J., Yang, X., Zhang, X., Liu, Z., Chilkoti, A., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0357-8 · Cited by 77
Emerging applications of bacteria as antitumor agents
Kalia, V. C., Patel, S. K. S., Cho, B., Wood, T. K., & Lee, J.-K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.012 · Cited by 81
Smith, R. S. H., Bader, C., Sharma, S., Kolb, D., Tang, T., Hosny, A., Moser, F., Weaver, J. C., Voigt, C. A., & Oxman, N. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201907401 · Cited by 91
Li, W.-Q., Wang, Z., Hao, S., Sun, L., Nisic, M., Cheng, G., Zhu, C., Wan, Y., Ha, L., & Zheng, S.-Y. (2018) · Nanoscale · doi:10.1039/c7nr08816g · Cited by 80
The microbiome in anti-cancer therapy
Bashiardes, S., Tuganbaev, T., Federici, S., & Elinav, E. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.001 · Cited by 80
An electrogenetic interface to program mammalian gene expression by direct current
Huang, J. B., Xue, S., Buchmann, P., Teixeira, A. P., & Fussenegger, M. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00850-7 · Cited by 85
Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy
Li, R., Helbig, L., Fu, J., Bian, X., Herrmann, J., Baumann, M., Stewart, A. F., Müller, R., Li, A., Zips, D., et al. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2018.11.001 · Cited by 73
Precision design of stable genetic circuits carried in highly‐insulated E. coli genomic landing pads
Park, Y., Borujeni, A. E., Gorochowski, T. E., Shin, J., & Voigt, C. A. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209584 · Cited by 78
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Chen, Y., Liu, B., Wei, Y., & Kuang, D.-M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105966 · Cited by 73
Genetically modified bacteria for targeted phototherapy of tumor
Deng, X., Yang, W., Shao, Z., & Zhao, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120809 · Cited by 74
Hartwig, O., Boushehri, M. A. S., Shalaby, K. S., Loretz, B., Lamprecht, A., & Lehr, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113828 · Cited by 74
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
Goto, Y., Iwata, S., Miyahara, M., & Miyako, E. (2023) · Advanced Science · doi:10.1002/advs.202301679 · Cited by 81
Autonomous bacterial nanoswimmers target cancer
Zoaby, N., Shainsky-Roitman, J., Badarneh, S., Abumanhal, H., Leshansky, A., Yaron, S., & Schroeder, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.006 · Cited by 68
Biosensor‐Based Microfluidic Platforms for Rapid Clinical Detection of Pathogenic Bacteria
Hou, Y., Liu, Z., Huang, H., Lou, C., Sun, Z., Liu, X., Pang, J., Ge, S., Wang, Z., Zhou, W., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202411484 · Cited by 76
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Bacteria‐Mediated Tumor Therapy via Photothermally‐Programmed Cytolysin A Expression
Wang, L., Qin, W., Xu, W., Huang, F., Xie, X., Wang, F., Ma, L., & Zhang, C. (2021) · Small · doi:10.1002/smll.202102932 · Cited by 74
Engineering microbial consortia with rationally designed cellular interactions
Deter, H. S., & Lu, T. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102730 · Cited by 71
Cell-based drug delivery systems for biomedical applications
Li, T., Dong, H., Zhang, C., & Mo, R. (2018) · Nano Research · doi:10.1007/s12274-018-2179-5 · Cited by 68
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Chen, Y., Wu, F., Wu, P., Xing, H., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935846 · Cited by 77
Genetic Circuit-Assisted Smart Microbial Engineering
Gao, C., Xu, P., Ye, C., Chen, X., & Liu, L. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.07.005 · Cited by 65
Tibbitt, M. W., & Langer, R. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00499 · Cited by 70
Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models
Wu, L., Ai, Y., Xie, R., Xiong, J., Wang, Y., & Liang, Q. (2023) · Lab on a Chip · doi:10.1039/d2lc00804a · Cited by 69
Dubuc, E., Pieters, P. A., van der Linden, A. J., van Hest, J. C. M., Huck, W. T. S., & de Greef, T. F. A. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.10.006 · Cited by 66
Zhou, X. W., Ling, K., Liu, M., Zhang, X., Ding, J., Dong, Y., Liang, Z., Li, J., & Zhang, J. (2019) · Theranostics · doi:10.7150/thno.35353 · Cited by 66
Biosensing in Smart Engineered Probiotics
Rottinghaus, A. G., Amrofell, M. B., & Moon, T. S. (2020) · Biotechnology Journal · doi:10.1002/biot.201900319 · Cited by 66
Photoelectric Bacteria Enhance the In Situ Production of Tetrodotoxin for Antitumor Therapy
Wang, X., Niu, M., Fan, J., Chen, Q., & Zhang, X. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00408 · Cited by 64
Recent advances in bacteria-mediated cancer therapy
Liang, S., Wang, C., Shao, Y., Wang, Y., Xing, D., & Geng, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1026248 · Cited by 71
Designer cells programming quorum-sensing interference with microbes
Sedlmayer, F., Hell, D., Müller, M., Ausländer, D., & Fussenegger, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04223-7 · Cited by 69
Qin, S., Liu, Y., He, G., Yang, H. J., Zeng, F., Lu, Q., Wang, M., He, B., & Song, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c08117 · Cited by 66
Bacteria-mediated cancer therapies: opportunities and challenges
Yang, M., Yang, F., Chen, W., Liu, S., Qiu, L., & Chen, J. (2021) · Biomaterials Science · doi:10.1039/d1bm00634g · Cited by 62
Achieving Spatial and Molecular Specificity with Ultrasound-Targeted Biomolecular Nanotherapeutics
Szablowski, J. O., Bar-Zion, A., & Shapiro, M. G. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00277 · Cited by 60
Relationship Between the Gut Microbiome and Systemic Chemotherapy
Ervin, S. M., Ramanan, S. V., & Bhatt, A. P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06119-3 · Cited by 67
Stability, robustness, and containment: preparing synthetic biology for real-world deployment
Kumar, S., & Hasty, J. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102880 · Cited by 59
Self-citationLi, F., Yang, Z., Savage, T. M., Vincent, R. L., Santos, K. D. L., Ahn, A., Rouanne, M., Mariuzza, D. L., Danino, T., & Arpaia, N. (2024) · Science Immunology · doi:10.1126/sciimmunol.adn9879 · Cited by 64
Self-citationTannic acid-based metal-phenolic networks as a versatile platform to mediate cell therapy
Luo, H., Xie, J., Su, X., Wang, P., Chen, H., Kuang, X., & Liu, J. (2024) · Science China Materials · doi:10.1007/s40843-024-3139-3 · Cited by 59
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
Advances in Synthetic Biology and Biosafety Governance
Li, J., Zhao, H., Zheng, L., & An, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.598087 · Cited by 91
The intratumoral microbiome: Characterization methods and functional impact
Heymann, C. J. F., Bard, J.-M., Heymann, M.-F., Heymann, D., & Bobin-Dubigeon, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.009 · Cited by 57
Zhang, Y., Xue, X., Fang, M., Pang, G., Xing, Y., Zhang, X., Li, L., Chen, Q., Wang, Y., Chang, J. K., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c14633 · Cited by 58
Zhang, Y., Kang, R., Zhang, X., Pang, G., Li, L., Han, C., Liu, B., Xue, X., Liu, J., Sun, T., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122147 · Cited by 65
Intratumoural production of TNFα by bacteria mediates cancer therapy
Murphy, C., Rettedal, E. A., Lehouritis, P., Devoy, C., & Tangney, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180034 · Cited by 63
The Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
Engineered Living Materials Based on Adhesin-Mediated Trapping of Programmable Cells
Guo, S., Dubuc, E., Rave, Y., Verhagen, M., Twisk, S. A. E., van der Hek, T., Oerlemans, G. J. M., van den Oetelaar, M. C. M., van Hazendonk, L. S., Brüls, M., et al. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00404 · Cited by 57
Advanced medical micro-robotics for early diagnosis and therapeutic interventions
Zhang, D., Gorochowski, T. E., Marucci, L., Lee, H., Rosa, B. M. G., Li, B., Hauert, S., & Yeatman, E. M. (2023) · Frontiers in Robotics and AI · doi:10.3389/frobt.2022.1086043 · Cited by 73
Novel strategies for modulating the gut microbiome for cancer therapy
Cho, Y. S., Han, K., Xu, J., & Moon, J. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115332 · Cited by 65
Maurya, R., Vikal, A., Patel, P., Narang, R. K., & Kurmi, B. D. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02940-5 · Cited by 74
Active matter logic for autonomous microfluidics
Woodhouse, F. G., & Dunkel, J. (2017) · Nature Communications · doi:10.1038/ncomms15169 · Cited by 67
Elements of biological oscillations in time and space
Cao, Y., Lopatkin, A. J., & You, L. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3320 · Cited by 57
Nanobodies: The Future of Antibody-Based Immune Therapeutics
Bathula, N. V., Bommadevara, H., & Hayes, J. M. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3941 · Cited by 63
Programming the lifestyles of engineered bacteria for cancer therapy
Fu, S., Zhang, R., Gao, Y., Xiong, J., Li, Y., Pu, L., Xia, A., & Jin, F. (2023) · National Science Review · doi:10.1093/nsr/nwad031 · Cited by 64
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., & Shen, S. (2023) · Advanced Science · doi:10.1002/advs.202205641 · Cited by 60
Bacteria synchronized for drug delivery
Zhou, S. (2016) · Nature · doi:10.1038/nature18915 · Cited by 55
Bacteria-based bioactive materials for cancer imaging and therapy
Chen, Y., Li, Z.-H., Zeng, X., & Zhang, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114696 · Cited by 54
Liu, W., Zhou, X., Yao, Q., Chen, C., Zhang, Q. H., Ding, K., Li, L., & Zeng, Z. (2023) · Journal of Clinical Investigation · doi:10.1172/jci157937 · Cited by 61
Microbe-material hybrids for therapeutic applications
Chen, M., Xia, L., Wu, C., Wang, Z., Ding, L. S., Xie, Y., Feng, W., & Chen, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00655g · Cited by 62
A scalable peptide-GPCR language for engineering multicellular communication
Billerbeck, S., Brisbois, J., Agmon, N., Jiménez, M., Temple, J., Shen, M. J., Boeke, J. D., & Cornish, V. W. (2018) · Nature Communications · doi:10.1038/s41467-018-07610-2 · Cited by 57
Biomimetic and bioinspired strategies for oral drug delivery
Hu, X., Yang, G., Chen, S., Luo, S., & Zhang, J. (2019) · Biomaterials Science · doi:10.1039/c9bm01378d · Cited by 56
Sedlmayer, F., Woischnig, A.-K., Unterreiner, V., Fuchs, F., Baeschlin, D. K., Khanna, N., & Fussenegger, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab251 · Cited by 59
Engineered bacteria as drug delivery vehicles: Principles and prospects
Zhou, Y., & Han, Y. C. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100034 · Cited by 56
Cao, F., Jin, L., Zhang, C., Gao, Y., Qian, Z., Wen, H., Yang, S., Ye, Z., Hong, L., Huang, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304257 · Cited by 66
Han, Z., Zhang, C., An, J., Wang, Y., Qiao, J., Zeng, X., & Zhang, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302728 · Cited by 53
Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy
Yang, Y., Wang, Y., Zeng, F., Chen, Y., Chen, Z., & Yan, F. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101512 · Cited by 73
In situ biomolecule production by bacteria; a synthetic biology approach to medicine
Bueso, Y. F., Lehouritis, P., & Tangney, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.023 · Cited by 54
Background-suppressed tumor-targeted photoacoustic imaging using bacterial carriers
Gao, R., Liu, F., Liu, W., Zeng, S., Chen, J., Gao, R., Wang, L., Fang, C., Song, L., Sedgwick, A. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121982119 · Cited by 51
Computing with biological switches and clocks
Dalchau, N., Szép, G., Hernansaiz-Ballesteros, R. D., Barnes, C. P., Cardelli, L., Phillips, A., & Csikász‐Nagy, A. (2018) · Natural Computing · doi:10.1007/s11047-018-9686-x · Cited by 55
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang, S., Huang, J., Jiang, Z., Tong, H., Ma, X., & Liu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00248-9 · Cited by 63
Bacterial variability in the mammalian gut captured by a single-cell synthetic oscillator
Riglar, D. T., Richmond, D., Potvin-Trottier, L., Verdegaal, A. A., Naydich, A. D., Bakshi, S., Leoncini, E., Lyon, L. G., Paulsson, J., & Silver, P. A. (2019) · Nature Communications · doi:10.1038/s41467-019-12638-z · Cited by 56
Nanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy
Chen, Y., Du, M., Yu, J., Rao, L., Chen, X. S., & Chen, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0008 · Cited by 51
A light tunable differentiation system for the creation and control of consortia in yeast
Aditya, C., Bertaux, F., Batt, G., & Ruess, J. (2021) · Nature Communications · doi:10.1038/s41467-021-26129-7 · Cited by 55
Han, C., Zhang, X., Pang, G., Zhang, Y., Pan, H., Li, L., Cui, M., Liu, B., Kang, R., Xue, X., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121619 · Cited by 52
Zhou, T., Wu, J., Tang, H., Liu, D., Jeon, B., Jin, W., Wang, Y., Zheng, Y., Khan, A., Han, H., et al. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00479-8 · Cited by 55
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy
Ijaz, M., Hasan, I., Chaudhry, T. H., Huang, R., Zhang, L., Hu, Z., Tan, Q., & Guo, B. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02786-w · Cited by 63
Synthetic Biology for Terraformation Lessons from Mars, Earth, and the Microbiome
Conde-Pueyo, N., Vidiella, B., Sardanyés, J., Berdugo, M., Maestre, F. T., de Lorenzo, V., & Solé, R. (2020) · Life · doi:10.3390/life10020014 · Cited by 49
Engineered bacteria launch and control an oncolytic virus
Singer, Z. S., Pabón, J., Huang, H., Sun, W. Y., Luo, H., Grant, K. R., Obi, I., Coker, C., Rice, C. M., & Danino, T. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01476-8 · Cited by 57
Self-citationSingh, R., Patil, S., Singh, N., & Gupta, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-06014-4 · Cited by 49
Wang, Y., Tang, Y., Du, Y., Lin, L., Zhang, Z., Ou, X., Chen, S., Wang, Q., & Zou, J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.07.056 · Cited by 51
An Orthogonal Multi-input Integration System to Control Gene Expression in Escherichia coli
Annunziata, F., Matyjaszkiewicz, A., Fiore, G., Grierson, C. S., Marucci, L., di Bernardo, M., & Savery, N. J. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00109 · Cited by 47
Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues
Chu, B., Yang, Y., Tang, J., Song, B., He, Y., & Wang, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202208422 · Cited by 47
Metadata
- Authors
- Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., & Hasty, J.
- Affiliations
- University of California San Diego (US)
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Corresponding author
- Hasty, Jeff
- ORCID
- Venue
- Nature
- Published
- 2016-07-20
- Volume
- 536
- Issue
- 7614
- Pages
- 81-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5048415
- OpenAlex
- W2480697384
- Cited by
- 784
- References
- 31
- Citations by year
- 2026: 97 · 2025: 107 · 2024: 95 · 2023: 87 · 2022: 73 · 2021: 71 · 2020: 82 · 2019: 59 · 2018: 55 · 2017: 43 · 2016: 12
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PMC
- Funders
- Howard Hughes Medical Institute
- University of California, San Diego
- National Cancer Institute (K99CA197649, R00CA197649, DP1CA174420, P30CA014051)
- National Institute of General Medical Sciences (P50GM085764, R01GM069811)
- National Institute of Environmental Health Sciences (P30ES002109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial lysis, quorum sensing, synthetic biology, Salmonella, pulsatile drug delivery, cancer therapy, colorectal cancer, liver metastasis, bacterial population dynamics, luminescent reporter, combination chemotherapy, oral administration, living therapeutics
- MeSH terms
- Administration, Oral, Animals, Bacteriolysis, Computer Simulation, Female, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Transplantation, Salmonella, Transplantation, Isogeneic, Colorectal Neoplasms, Drug Delivery Systems, Coculture Techniques, Luminescence, Mice, Quorum Sensing, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.